aTyr Pharma Inc. (LIFE) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    aTyr Pharma Inc.

    NASDAQ: LIFE · Real-Time Price · USD
    1.90
    0.05 (2.70%)
    At close: Jun 04, 2024, 10:00 PM

    aTyr Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 11.05M 22.54M 9.98M 2.34M
    Short-Term Investments
    		 n/a 75.62M 56.16M 105.58M
    Long-Term Investments
    		 n/a 3.48M n/a n/a
    Other Long-Term Assets
    		 3.02M -1.28M 3.14M n/a
    Receivables
    		 1.74M 2.44M 11.78M 435K
    Inventory
    		 n/a n/a -2.95M n/a
    Other Current Assets
    		 69.16M -75.62M 3.17M 5.38M
    Total Current Assets
    		 81.95M 102.99M 81.09M 113.73M
    Property-Plant & Equipment
    		 11.86M 14.05M 11.56M 1.81M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 14.88M 17.66M 14.7M 1.81M
    Total Assets
    		 96.83M 120.65M 95.79M 115.54M
    Account Payables
    		 4.32M 3.53M 3.11M 1.03M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 1.25M 1.33M 894K 980K
    Other Current Liabilities
    		 13.71M 11.56M 9.86M 4M
    Total Current Liabilities
    		 14.97M 16.42M 13.86M 6.01M
    Long-Term Debt
    		 12.03M 13.77M 10.64M 398K
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 12.03M 15.18M 10.64M 398K
    Total Liabilities
    		 26.81M 30.18M 24.5M 6.41M
    Total Debt
    		 13.28M 15.1M 11.53M 1.38M
    Book Value
    		 70.02M 90.47M 71.28M 109.13M
    Book Value Per Share
    		 0.92 1.69 2.51 5.72
    Common Stock
    		 84K 63K 29K 28K
    Retained Earnings
    		 -532.05M -468.02M -417.63M -372.3M
    Comprehensive Income
    		 -40K -74K -433K -263K
    Shareholders Equity
    		 70.02M 90.66M 71.28M 109.13M
    Total Investments
    		 n/a 79.11M 56.16M 105.58M

    Add to Watchlist